AmerisourceBergen 2011 Annual Report Download - page 12

Our packaging and consulting
businesses work together to develop
innovative programs to drive patient
adherence to complex therapies
and improve patient outcomes.
search for ways to
provide better care
with fewer resources,
AmerisourceBergen will
continue to invest in our
core business to drive
innovative solutions across
the pharmaceutical supply
channel. In November 2011,
we acquiredTheraCom,
which became part of
AmerisourceBergen
Consulting Services (ABCS).
The addition ofTheraCom
nearly doubled the size of
our consulting services operations, and meaningfully
expanded our portfolio of services that support
manufacturers.While ABCS historically has focused
on reimbursement support and other services for
pharmaceuticals that were typically covered by the
medical benefit,TheraCom focuses on products that
are covered by the pharmacy benefit.The expertise
that ABCS provides on reimbursement, patient copay
and other assistance programs, adherence programs,
and other services are now available for virtually any
pharmaceutical product on the market today, or in
the pipeline.With the additional acquisition of
Premier Source in late fiscal 2011, which specializes
in reimbursement services for molecular diagnostic
services and emerging biotech products,ABCS is
now a comprehensive manufacturer services provider
with over 3,000 associates dedicated to helping
manufacturers demonstrate the value of their products
to patients and to payers.
In October of 2011, we combined our consulting
services businesses with our manufacturer-focused
packaging businesses to take advantage of the expertise
in both organizations in order to drive better value
for manufacturers.We have also combined our
contract and clinical trial packaging businesses under
AndersonBrecon, which now has over 1,500 associates
and over one million square feet of packaging
facilities in the U.S. and in the United Kingdom.
AndersonBrecon expanded its packaging capabilities
in fiscal 2011 to include specialty pharmaceutical
and potent compound packaging capabilities, and
has continued to expand its clinical trials packaging
capabilities. From dry oral solids and powders to
liquids and potent injectibles, we offer manufacturers
very high quality, innovative packaging which helps
ensure their products get safely to market. In addition,
our packaging and consulting businesses work
together to drive patient compliance and adherence
to complex therapies, which ultimately leads to better
outcomes for patients.
As health reform initiatives aim to improve the
quality of care while driving down costs across the
entire spectrum of healthcare, we believe that demand
for the products and services that AmerisourceBergen
provides will increase. Generic pharmaceuticals
will continue to play a key role in managing costs,
and specialty pharmaceuticals will continue to be
important contributors to improving the lives of
patients with the most intractable illnesses. Our
innovative solutions and services help increase the
efficiency with which pharmaceuticals are brought to
market and dispensed to patients and enhance patient
adherence to pharmaceutical therapies with the
ultimate goal of achieving better patient outcomes.
As we look ahead, we see many opportunities on
the horizon to continue to invest in our business
to meet the changing needs of the marketplace,
and to continue to drive value for our provider and
manufacturer customers, and for our stockholders.
ABCS is a comprehensive
manufacturer services provider,
delivering world-class
reimbursement solutions and
state-of-the-art packaging
capabilities to global markets.
10
continued from previous page